In Brief: OTC vaginal contraceptives
This article was originally published in The Tan Sheet
Executive Summary
OTC vaginal contraceptives: American College of Nurse-Midwives tells FDA that removal of OTC status for vaginal contraceptives should not be undertaken "without strong evidence that these products pose a significant hazard to the health of their users." The Association for the Advancement of Health Care, in separate comments on FDA's proposal to require NDAs/ANDAs for OTC contraceptives, said FDA's proposal is "ill-advised" and will have a "negative impact" on availability of "affordable, reliable contraceptive options." Other industry and health professionals groups also have opposed the proposal ("The Tan Sheet" June 19, pp. 9-12)...